Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Clinical predictors of one-year mortality after acute coronary syndrome: the APULIA PONTE ACS registry.
Anno:
2023
Background. Risk stratification in patients discharged from hospital after coronary syndrome (ACS) play a central role in the management the patients during follow-up. The aim of study was to evaluate the clinical predictors of one-year mortality  after ACS. Methods. We analysed data from 2011 participants of Apulia Ponte ACS…
Leggi di più
INTRAMYOCARDIAL HAEMATOMA AS A COMPLICATION OF ACUTE MYOCARDIAL INFARCTION
Anno:
2023
A 72-year-old overweight man, with known hypertension and dyslipidaemia, had an episode of high intensity chest pain, which appeared at rest and lasted for several hours. A few days later, he underwent a cardiological examination and the electrocardiogram showed normofrequent sinus rhythm, ST elevation of 3 mm and Q…
Leggi di più
COME LA PANDEMIA DA COVID-19 HA MODIFICATO L’EPIDEMIOLOGIA DEI PAZIENTI AFFETTI DA SINDROME CORONARICA ACUTA SENZA SOPRASLIVELLAMENTO DEL TRATTO ST-T. DATI DI UN SINGOLO CENTRO.
Anno:
2023
Background: La pandemia da COVID-19 ha determinato negli ultimi anni un profondo cambiamento del quadro epidemiologico e dell’incidenza delle malattie cardiovascolari così come descritto in numerosi report presenti in letteratura. Tale condizione può essere attribuita a vari fattori tra cui riduzione dei ricoveri per SCA (sindrome coronarica acuta) già…
Leggi di più
The tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT) trial, 2023 updates.
Anno:
2023
Introduction: the role of beta blockers (BB) post-myocardial infarction (MI) in patients without reduced ejection fraction in the era of invasive management is controversial. Results from observational studies have led to opposite results.  Methods: REBOOT is an independent multinational pragmatic, controlled, randomized, open-label, with blinded endpoint adjudication clinical trial….
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram